Background & Aims
Cirrhosis is associated with significant pain and disability, the etiologies of which are poorly understood. We investigated whether the pain and disability in patients with cirrhosis are associated with systemic inflammation and psychiatric symptoms.
Methods
In a prospective study, we recruited 193 patients with cirrhosis caused by hepatitis C virus (HCV) infection, non-alcoholic steatohepatitis (NASH), or alcohol from the hepatology clinic at the University of Pittsburgh. Patients were assessed using the McGill Pain Questionnaire, Hospital Anxiety and Depression Scale (HADS), Pittsburgh Sleep Quality Index (PSQI), and the Pain Disability Index. Serum samples were collected and markers of inflammation were measured using standardized Luminex assays. We evaluated factors associated with pain, pain-related disability, and chronic opioid use using multivariable regression models.
Results
Pain was reported by 79% of patients, pain-related disability by 75%, and depression and/or anxiety by 47%; the average Model for End-Stage Liver Disease (MELD) score was=12±5. Serum samples from 58% percent of patients had increased levels of c-reactive protein (CRP). Opioids were prescribed for 30% of patients with pain. In multivariate analysis, factors significantly associated with pain included younger age (odds ratio [OR]/year=0.93; 95% confidence interval [CI], 0.90–0.99), serum level of interleukin 6 (OR=1.63, 95% CI=1.09–2.58), HADS score (OR/point=1.14; 95% CI, 1.07–1.24), and etiology (HCV infection vs alcohol, OR=3.70; 95% CI, 1.27–11.11). Disability scores were significantly related to psychiatric symptoms (incidence rate ratio [IRR]/point=1.04; 95% CI, 1.02–1.05), prescription opioid use (IRR=1.49; 95% CI, 1.14–1.94), MELD score (IRR/point=1.02; 95% CI, 1.0001–1.05), level of CRP (IRR=1.13; 95% CI, 1.02–1.24), and pain severity (IRR/point=1.19; 95% CI, 1.08–1.32).
Conclusion
Pain and disability are common among patients with cirrhosis, and are associated with inflammation, psychiatric symptoms, and opioid use, which are potentially modifiable. Although opioids are commonly used to treat pain, psychiatric symptoms and inflammation might also be treatment targets in this population.